ACLS Stock Recent News
ACLS LATEST HEADLINES
Axcelis Technologies (ACLS) came out with quarterly earnings of $1.49 per share, beating the Zacks Consensus Estimate of $1.43 per share. This compares to earnings of $1.99 per share a year ago.
Revenue of $256.6 million Operating margin of 18.3% Diluted earnings per share of $1.49 BEVERLY, Mass. , Nov. 6, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS) today announced financial results for the third quarter ended September 30, 2024.
ACLS' third-quarter performance is likely to have benefited from solid demand for ion implantation systems, especially in the silicon carbide space.
The Zacks Electronics - Manufacturing Machinery industry participants, such as Entegris (ENTG), MKS Instruments (MKSI) and Axcelis Technologies (ACLS), are benefiting from increased capital spending on high-performance computing, advanced packaging and memory.
BEVERLY, Mass. , Oct. 16, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry will release financial results for the third quarter 2024 on Wednesday, November 6, 2024, at 4:00 p.m.
ASO, AVD and ACLS have been added to the Zacks Rank #24 (Strong Sell) List on September 25, 2024.
BEVERLY, Mass. , Sept. 24, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, will be participating in the International Conference on Silicon Carbide and Related Materials (ICSCRM 2024) taking place September 29 - October 4, 2024, at the Raleigh Convention Center in North Carolina.
BEVERLY, Mass. , Sept. 4, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, will be a top-level Platinum Sponsor at the International Conference on Ion Implantation Technology 2024 (IIT 2024) taking place September 23-26 at the Toyama International Conference Center in Japan.
Showcase Features the Purion and GSD Ovation Series of Ion Implanters Designed to Deliver Significant Technology and Manufacturing Advantages BEVERLY, Mass. , Aug. 29, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today that it will showcase its Purion™ and GSD Ovation™ Series of ion implanters at the inaugural SEMICON India 2024, India's premier semiconductor event.
BEVERLY, Mass. , Aug. 8, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced the company's plans to participate in the following upcoming investor conferences, at which management will be available for one-on-ones and small group meetings.